These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

653 related items for PubMed ID: 25837159

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Distinct Gene Expression Patterns Defining Human Osteoblasts' Response to BMP2 Treatment: Is the Therapeutic Success All a Matter of Timing?
    Ehnert S, Aspera-Werz RH, Freude T, Reumann MK, Ochs BG, Bahrs C, Schröter S, Wintermeyer E, Nussler AK, Pscherer S.
    Eur Surg Res; 2016; 57(3-4):197-210. PubMed ID: 27441597
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of TNFα secreted from macrophages activated by titanium particles on osteogenic activity regulated by WNT/BMP signaling in osteoprogenitor cells.
    Lee SS, Sharma AR, Choi BS, Jung JS, Chang JD, Park S, Salvati EA, Purdue EP, Song DK, Nam JS.
    Biomaterials; 2012 Jun; 33(17):4251-63. PubMed ID: 22436801
    [Abstract] [Full Text] [Related]

  • 6. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
    Kamiya N, Kobayashi T, Mochida Y, Yu PB, Yamauchi M, Kronenberg HM, Mishina Y.
    J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
    [Abstract] [Full Text] [Related]

  • 7. Low sirtuin 1 levels in human osteoarthritis subchondral osteoblasts lead to abnormal sclerostin expression which decreases Wnt/β-catenin activity.
    Abed É, Couchourel D, Delalandre A, Duval N, Pelletier JP, Martel-Pelletier J, Lajeunesse D.
    Bone; 2014 Feb; 59():28-36. PubMed ID: 24184155
    [Abstract] [Full Text] [Related]

  • 8. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW, Barlogie B, Rudikoff S, Shaughnessy JD.
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [Abstract] [Full Text] [Related]

  • 9. Bone morphogenetic protein-2 enhances Wnt/beta-catenin signaling-induced osteoprotegerin expression.
    Sato MM, Nakashima A, Nashimoto M, Yawaka Y, Tamura M.
    Genes Cells; 2009 Feb; 14(2):141-53. PubMed ID: 19170762
    [Abstract] [Full Text] [Related]

  • 10. Induction of estrogen receptor α-36 expression by bone morphogenetic protein 2 in breast cancer cell lines.
    Wang D, Huang P, Zhu B, Sun L, Huang Q, Wang J.
    Mol Med Rep; 2012 Sep; 6(3):591-6. PubMed ID: 22711074
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway.
    Kamiya N, Ye L, Kobayashi T, Mochida Y, Yamauchi M, Kronenberg HM, Feng JQ, Mishina Y.
    Development; 2008 Nov; 135(22):3801-11. PubMed ID: 18927151
    [Abstract] [Full Text] [Related]

  • 14. Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor.
    Kousteni S, Almeida M, Han L, Bellido T, Jilka RL, Manolagas SC.
    Mol Cell Biol; 2007 Feb; 27(4):1516-30. PubMed ID: 17158928
    [Abstract] [Full Text] [Related]

  • 15. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
    Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR, Fazzalari NL, Evdokiou A, Atkins GJ.
    J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
    [Abstract] [Full Text] [Related]

  • 16. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand.
    Wang QP, Yang L, Li XP, Xie H, Liao EY, Wang M, Luo XH.
    Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178
    [Abstract] [Full Text] [Related]

  • 17. A protein kinase A (PKA)/β-catenin pathway sustains the BMP2/DLX3-induced osteogenic differentiation in dental follicle cells (DFCs).
    Viale-Bouroncle S, Klingelhöffer C, Ettl T, Reichert TE, Morsczeck C.
    Cell Signal; 2015 Mar; 27(3):598-605. PubMed ID: 25530217
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
    Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, Gazit D.
    Mol Endocrinol; 2003 Jan; 17(1):56-66. PubMed ID: 12511606
    [Abstract] [Full Text] [Related]

  • 20. Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.
    Lin C, Jiang X, Dai Z, Guo X, Weng T, Wang J, Li Y, Feng G, Gao X, He L.
    J Bone Miner Res; 2009 Oct; 24(10):1651-61. PubMed ID: 19419300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.